EAM Global Investors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-22,893
| Closed | -$2.52M | – | 214 |
|
2022
Q4 | $2.52M | Sell |
22,893
-50,863
| -69% | -$5.59M | 0.65% | 38 |
|
2022
Q3 | $4.35M | Buy |
+73,756
| New | +$4.35M | 1.16% | 13 |
|
2022
Q2 | – | Sell |
-57,073
| Closed | -$2.16M | – | 285 |
|
2022
Q1 | $2.16M | Hold |
57,073
| – | – | 0.4% | 114 |
|
2021
Q4 | $2.26M | Buy |
+57,073
| New | +$2.26M | 0.4% | 134 |
|